The Role Of Microbiota-Derived Small Molecules in the Etiology of Crohn’s Disease.

Epithelial Fucosylation, Microbiota and Inflammatory Bowel Disease.

Control of Innate Lymphoid Cells and Intestinal Homeostasis by Neurotrophic Factors.

Nanofibers of Self-Assembled De Novo Glycoconjugates for Mucosal Lining Restoration and Anti-Inflammatory Drug Delivery.

Gastric Control of Intestinal Function.

Synthetic Engineering of Enhanced Fitness and Adhesion Properties in Probiotics for the treatment of Inflammatory Bowel Disease.

Potential of Parasite Products to Suppress Inflammatory Bowel Disease.

Development of a Fecal Microbiota Transplant Mouse Model for Ulcerative Colitis to Identify Pro-and Anti-inflammatory Bacteria.

A Novel Mouse Model to Study the Molecular Basis of Chronic Inflammation in Inflammatory Bowel Disease.

Treating Inflammatory Bowel Disease by Enhancing HNF-4a Activity.